Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
23%
OVERLAP
BY WEIGHT
16
# OF OVERLAPPING
HOLDINGS
HRTS
43
HOLDINGS
37%
ALSO IN WDNA
WDNA
90
HOLDINGS
19%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 7.8% | 2.7% | 2.7% |
|
BRIDGEBIO PHARMA, INC. | 2.9% | 2.4% | 2.4% |
|
GILEAD SCIENCES INC | 3.4% | 1.9% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 2.6% | 1.8% | 1.8% |
|
AMGEN INC | 2.5% | 1.7% | 1.7% |
HRTS Overweight Relative to WDNA
|
ELI LILLY & CO | 5.1% |
|
ABBOTT LABORATORIES | 4.7% |
|
UNITEDHEALTH GROUP INC | 4.6% |
 |
ASTRAZENECA PLC | 4.5% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.2% |
|
BOSTON SCIENTIFIC CORP | 3.9% |
|
ABBVIE INC | 3.5% |
 |
NOVO NORDISK A/S-B | 3.5% |
 |
MEDTRONIC PLC | 3.0% |
|
CRINETICS PHARMACEUTICALS INC | 2.6% |
HRTS Underweight Relative to WDNA
|
NATERA INC | -3.7% |
|
TWIST BIOSCIENCE CORP. | -3.3% |
|
NOVOZYMES A/S-B SHARES | -2.9% |
|
VERICEL CORPORATION | -2.6% |
|
BLUEPRINT MEDICINES CORP. | -2.6% |
|
VERACYTE INC | -2.1% |
|
AGIOS PHARMACEUTICALS INC | -1.9% |
|
UNITED THERAPEUTICS CORP | -1.7% |
|
LABCORP HOLDINGS | -1.5% |
|
DUPONT DE NEMOURS INC | -1.5% |